Background
Gender differences in dyslipidemia are widely documented, but the contributors
to these differences are not well understood. This study examines whether differences in
quality of care, intensity of lipid- lowering medication regimen and medication
adherence can explain this disparity.
Methods
Secondary analysis of medical records data and questionnaires collected from
adult patients with type 2 diabetes (n=1,369) from seven outpatient clinics
affiliated with an academic medical center as part of the Reducing Racial Disparities in
Diabetes: Coached Care (R2D2C2) study. Primary outcome was LDL cholesterol.
Findings
Women had higher LDL cholesterol levels than men (mean[SD]:
101.2[35.2] mg/dl vs. 92.3[33.0] mg/dl,
p<0.001), but were no less likely to receive recommended processes of diabetes
care, to attain targets for glycemic control and blood pressure, or to be on intensive
medication regimens. More women than men reported medication nonadherence due to cost
(32.7% vs. 24.2%, p=0.040) and due to side effects
(47.2% vs. 36.8%, p=0.024). For all patients, regimen intensity
(p<0.05) and nonadherence due to side effects (p<0.01) were each
associated with higher LDL cholesterol levels. The addition of a new lipid lowering
agent was associated with subsequent nonadherence related to side effects for women
(p<0.001), but not for men (p=0.45, test for interaction
p=0.048).
Conclusions
Despite comparable quality of diabetes care and regimen intensity for lipid
management, women with diabetes experienced poorer lipid control than men. Medication
nonadherence appeared to be a major contributor to dyslipidemia, particularly for women,
because of side effects associated with intensifying the lipid lowering regimen.